ALTERED SIGNALING TRIGGERED BY LIGATION OF THE TCR/CD3 RECEPTOR IN T LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE ROAD FROM ANERGY TO AUTOIMMUNITY

REFERENCES

• J., Alcocer-Varela, D., Alarcon-Segovia. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus, J. Clin. Invest. 69: 388–1392, 1982
   Google Scholar
• M., Linker-Israeli, A.C., Bakke, R.C., Kitridou, S., Gendler, G., Gillis, D.A., Horwitz. Defective production of interleukin 1 and 2 in patients with systemic lupus erythematosus (SLE). J. Immunol.. 130: 2651–2655, 1983
   PubMed Web of Science ®Google Scholar
• E.E., Solomon, Y.T., Juang, M.F., Gourley, G.M., Kammer, G.C., Tsokos. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol. 166: 4216–4222, 2001
   Google Scholar
• I.L., Stekman, A.M., Blasini, M., Leon-Ponte, M.L., Baroja, I., Abadí, M.A., Rodríguez. Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erithematosus. Arthritis Rheum.. 34: 459–467, 1991
   PubMed Web of Science ®Google Scholar
• B., Kovacs, D., Vassilopoulos, S.A., Vogelgesang, G.S., Tsokos. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-alpha. Clin. Immunol. Immunopathol.. 81: 293–302, 1996, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• T.W., McKeithan. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA. 92: 5042–5046, 1995, [CSA]
   PubMed Web of Science ®Google Scholar
• J.D., Rabinowitz, D.C., Beeson, D.S., Lyons, M.M., Davis, H.M., McConnell. Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA. 93: 1401–1405, 1996, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A., Bhandoola, E.A., Cho, K., Yui, U., Saragovi, M.I., Greene, H., Quill. Reduced CD3-mediated protein tyrosine phosphorylation in anergic CD4+ and CD8+ T cells. J. Immunol.. 151: 2355–2367, 1993
   PubMedGoogle Scholar
• Y., Boutin, D., Leitenberg, X., Tao, K., Bottomly. Distinct biochemical signals characterize agonist- and altered peptide ligand-induced differentiation of naive CD4 + T cells into Th1 and Th2 subsets. J. Immunol.. 159: 5802–5809, 1997
   PubMed Web of Science ®Google Scholar
• D.C., Tsitoura, W., Holter, A., Cerwenka, C.M., Gelder, J.R., Lamb. Induction of anergy in human T helper O cells by stimulation with altered T cell antigen receptor ligands. J. Immunol.. 156: 2801–2808, 1996
   PubMedGoogle Scholar
• L.C., Korb, S., Mirshahidi, K., Ramyar, A.A.S., Akha, S., Sadegh-Nasseri. Induction of T cell anergy by low numbers of agonist ligands. J. Immunol.. 162: 6401–6409, 1999
   PubMedGoogle Scholar
• K., Migita, K., Eguchi, Y., Kawabe, T., Tsukada, Y., Ichinose, S., Nagataki. Defective TCR-mediated signaling in anergic T cells. J. Immunol.. 155: 5083–5087, 1995 K
   PubMedGoogle Scholar
• K., Salojin, J., Zhang, M., Cameron, B., Gill, G., Arreaza, A., Ochi, T.L., Delovitch. Impaired plasma membrane targeting of Grb2-murine Son of Sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-ζ-Cbl pathway mediated T cell hyporesponsivennes in autoimmune nonobese diabetic mice. J. Exp. Med.. 186: 887–897, 1997, [CROSSREF]
   PubMedGoogle Scholar
• K.V., Salojin, J., Zhang, J., Madrenas, T.L., Delovitch. T-cell anergy and altered T-cell receptor signaling: Effects on autoimmune disease. Immunol. Today. 19: 468–473, 1998, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• S.I., Gringhuis, A., Leow, E.A.M., Papendrecht-vander Voort, P.H.J., Remans, F.C., Breedveld, C.L., Verweij. Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J. Immunol.. 164: 2170–2179, 2000
   Google Scholar
• S.N.C., Liossis, X.Z., Ding, G.J., Dennis, G.S., Tsokos. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Invest.. 101: 1448–1457, 1998, [CSA]
   PubMed Web of Science ®Google Scholar
• V., Brundula, L., Rivas, A.M., Blasini, M., Paris, S., Salazar, I.L., Stekman, M.A., Rodríguez. Diminished levels of TCR ζ chain in peripheral blood (PB) T lymphocytes from patients with systemic lupus erithematosus (SLE). Arthritis Rheum.. 42: 1908–1916, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• J.D., Klemm, S.L., Schreiber, G.R., Crabtree. Dimerization as a regulatory mechanism in signal transduction. Ann. Rev. Immunol.. 16: 569–592, 1998, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• E.N., Kersh, A.S., Shaw, P.M., Allen. Fidelity of T cell activation through multistep T cell receptor ζ phosphorylation. Science. 281: 572–575, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• B., Johansson, E., Palmer, L., Bolliger. The extracellular domain of the ζ-chain is essential for TCR function. J. Immunol.. 162: 878–885, 1999
   PubMed Web of Science ®Google Scholar
• B., Combadiere, M., Freedman, L., Chen, E.W., Shores, P., Love, M.J., Lenardo. Qualitative and quantitative contributions of the T cell receptor ζ chain to mature T cell apoptosis. J. Exp. Med.. 183: 2109–2117, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• K., Tsuzaka, T., Takeuchi, M., Pang, N., Onoda, T., Abe. Mutations in T cell receptor ζ chain mRNA of peripheral T cells from systemic lupus erythematosus. J. Autoimmun.. 11: 381–385, 1998, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.P., Nambiar, E.J., Enyedi, V.G., Warke, S., Krishnan, G., Dennis, H.K., Wong, G.M., Kammer, G.S., Tsokos. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor ζ chain messenger. Arthritis Rheum.. 44: 1336–1350, 2001, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G.M., Kammer, A., Perl, B.C., Richardson, G.C., Tsokos. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum.. 46: 1139–1154, 2002, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.M., Blasini, R., Chacon, R., Riera, I.L., Stekman, M.A., Rodriguez. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes form patients with systemic lupus erythematosus. Lupus. 7: 515–523, 1998, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M., Matache, M., Stefanescu, A., Onu, G., Szegli, M., Barel, S., Tanseanu, I., Matei, S., Bouillie, R., Frade. Tyrosine phosphorylation in peripheral lymphocytes from patients with systemic lupus erythematosus. Autoimmunity. 24: 217–228, 1996, [CSA]
   PubMed Web of Science ®Google Scholar
• E.J., Enyedi, M.P., Nambiar, H.K S.N.C., Liossis, G., Dennis, G.M., Kammer, G.C., Tsokos. Fcε receptor type I γ chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum.. 44. 1114–1121, 2001
   Google Scholar
• A.M., Blasini, V., Brundula, M., Paris, L., Rivas, S., Salazar, I.L., Stekman, M.A., Rodriguez. Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus. J. Autoimmun.. 11: 387–393, 1998
   Google Scholar
• T., Katagiri, J.P., Ting, R., Dy, C., Prokop, P., Cohen, H.S., Earp. Tyrosine phosphorylation of a c-src like protein is increased in membranes of CD4-CD8-T lymphocytes from lpr/lpr mice. Mol. Cell. Biol.. 9: 4914–4922, 1989
   PubMedGoogle Scholar
• H., Quill, M.P., Riley, E.A., Cho, J.E., Casnellie, J.C., Reed, T., Torigoe. Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J. Immunol.. 149: 2887–2893, 1992
   PubMedGoogle Scholar
• J., Huang, D., Tilly, A., Altman, K., Sugie, H.M., Grey. T-cell receptor antagonists induce Vav phophorylation by selective activation of fyn kinase. Proc. Natl. Acad. Sci. USA. 97: 10923–10929, 2000, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• A., Cherukuri, M., Dykstra, S.K., Pierce. Floating the raft hypothesis: Lipid rafts play a role in immune cell activation. Immunity. 14: 657–660, 2001, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.E., Samelson, A.F., Phillips, E.T., Wong, R.D., Klausner. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA. 87: 4358–4362, 1990, [CSA]
   PubMed Web of Science ®Google Scholar
• T., Takeuchi, M., Pang, K., Amano, J., Koide, T., Abe. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SE). Clin. Exp. Immunol.. 109: 20–26, 1997, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.L., Hermiston, X., Zheng, R., Majeti, A., Weiss. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J Clin. Invest.. 109: 9–14, 2002, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M.P., Nambiar, E.J., Enyedy, C.U., Fisher, S., Krishnan, V.G., Warke, W.R., Gilliland, R.J., Oglesby, G.S., Tsokos. Abnormal expression of various molecular forms and distribution of T cell receptor ζ chain in patients with systemic lupus erythematosus. Arthritis Rheum.. 46: 163–174, 2002, [CROSSREF]
   PubMedGoogle Scholar
• A., Leo, J., Wienands, G., Baier, V., Horejsi, B., Schraven. Adapters in lymphocyte signaling. J. Clin. Invest.. 109: 301–309, 2002, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W., Zhang, R.P., Trible, M., Zhu, S.K., Liu, C.J., McGlade, L.E., Samelson. Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell antigen receptor-mediated signaling. J Biol. Chem.. 275: 2335–2336, 2000, [CROSSREF]
   PubMedGoogle Scholar
• S., Cedeno, D.F., Cifarelli, A.M., Blasini, M., Paris, F., Placeres, G., Alonso, M.A., Rodríguez. Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras nucleotide exchange factor hSos to adapter protein Grb2 lupus T cells. Clin. Immunol.. 106: 41–49, 2003, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C., Deng, M.J., Kaplan, J., Yang, D., Ray, Z., Zhang, W.J., McCune, S.M., Hanash, B.C., Richardson. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 44: 397–407, 2001, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• W., Li, C.D., Whaley, A., Mondino, D.L., Mueller. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4 + T cells. Science. 271: 1272–1276, 1996
   PubMed Web of Science ®Google Scholar
• P.E., Fields, T.F., Gajewski, F.W., Fitch. Blocked Ras activation in anergic CD4 + T cells. Science. 271: 1276–1278, 1996
   PubMed Web of Science ®Google Scholar
• I., Horak, J., Lohler, A., Ma, K.A., Smith. Interleukin-2 deficient mice: A new model to study autoimmunity and self-tolerance. Immunol. Rev.. 148: 35–44, 1995, [CSA]
   PubMed Web of Science ®Google Scholar
• H., Suzuki, T.M., Kundig, C., Furlonger, A., Wakeman, E., Timms, T., Matsuyama, R., Schmits, J.J., Simard, P.S., Ohashi, H., Griesser, T., Taniguchi, C.J., Paige, T.W., Mak. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 9: 1472–1476, 1995
   Google Scholar
• T.R., Malek, B.O., Porter, E.K., Codias, P., Sciberlli, A., Yu. Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J. Immunol.. 15: 2905–2914, 2000
   Google Scholar
• B.R., Ludviksson, B., Gray, W., Strober, R.O., Ehrhardt. Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J. Immunol.. 158: 104–11, 1997
   PubMedGoogle Scholar
• L.G., Radvanyi, K., Raju, D., Spaner, G.B., Mills, R.G., Miller. Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice. Cell. Immunol.. 183: 1–12, 1998, [CSA], [CROSSREF]
   PubMedGoogle Scholar